Terms: = Prostate cancer AND DDR2, NTRKR3, 4921, ENSG00000162733, Q16832, MIG20a, TYRO10 AND Treatment
5 results:
1. Interleukin (IL)-22 from IL-20 Subfamily of Cytokines Induces Colonic Epithelial Cell Proliferation Predominantly through ERK1/2 Pathway.
Moniruzzaman M; Wang R; Jeet V; McGuckin MA; Hasnain SZ
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31311100
[TBL] [Abstract] [Full Text] [Related]
2. Incidence and risk of cardiotoxicity in cancer patients treated with targeted therapies.
Santoni M; Guerra F; Conti A; Lucarelli A; Rinaldi S; Belvederesi L; Capucci A; Berardi R
Cancer Treat Rev; 2017 Sep; 59():123-131. PubMed ID: 28818671
[TBL] [Abstract] [Full Text] [Related]
3. Targeting ddr2 in head and neck squamous cell carcinoma with dasatinib.
von Mässenhausen A; Sanders C; Brägelmann J; Konantz M; Queisser A; Vogel W; Kristiansen G; Duensing S; Schröck A; Bootz F; Brossart P; Kirfel J; Lengerke C; Perner S
Int J Cancer; 2016 Nov; 139(10):2359-69. PubMed ID: 27434411
[TBL] [Abstract] [Full Text] [Related]
4. Discoidin domain receptor 2 facilitates prostate cancer bone metastasis via regulating parathyroid hormone-related protein.
Yan Z; Jin S; Wei Z; Huilian H; Zhanhai Y; Yue T; Juan L; Jing L; Libo Y; Xu L
Biochim Biophys Acta; 2014 Sep; 1842(9):1350-63. PubMed ID: 24787381
[TBL] [Abstract] [Full Text] [Related]
5. The intracellular juxtamembrane domain of discoidin domain receptor 2 (ddr2) is essential for receptor activation and ddr2-mediated cancer progression.
Kim D; Ko P; You E; Rhee S
Int J Cancer; 2014 Dec; 135(11):2547-57. PubMed ID: 24740739
[TBL] [Abstract] [Full Text] [Related]
